Peregrine Pharmaceuticals Inc.
14282 Franklin Avenue
Tustin,
CA 92780-7017
United States - Map
Phone: 714-508-6000
Fax: 714-838-5817
Web Site: http://www.peregrineinc.com
| Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development and manufacture of monoclonal antibodies for the treatment of cancer and viral infections. The company develops clinical programs with its novel compounds bavituximab and Cotara, which are the clinical candidates under its anti-phosphatidylserine therapeutics and tumor necrosis therapy platforms. Its pipeline products comprise Bavituximab Plus Docetaxel, and Bavituximab plus carboplatin and paclitaxel, which are Phase II clinical trial products for treating advanced breast cancer patients; and Bavituximab plus carboplatin and paclitaxel, a Phase II clinical trial product for the treatment of non-small cell lung cancer, as well as Bavituximab, which is in Phase I monotherapy repeat dose safety study for treating solid tumor cancers, and in Phase Ib repeat dose safety study for the treatment of chronic hepatitis C virus infection co-infected with HIV. In addition, its pipeline products include Cotara, a product in Phase II, as well as a dosimetry and dose confirmation study for the treatment of glioblastoma multiforme, an aggressive form of brain cancer. Further, Peregrine, through its wholly owned subsidiary, Avid Bioservices, Inc., provides contract manufacturing services for biotechnology and biopharmaceutical companies, from pre-clinical drug supplies up through commercial-scale drug manufacture. Further, it provides services in support of Peregrine's product pipeline, including manufacture and scale-up of pre-clinical and clinical drug supplies. The company was founded in 1981 and is based in Tustin, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Steven W. King , 46
Chief Exec. Officer, Pres, Director, Chief Exec. Officer of Avid Bioservices Inc and Pres of Avid Bioservices Inc |
$
407.00K |
$
0 | Mr. Paul J. Lytle , 42
Chief Financial Officer, Principal Accounting Officer, Corp. Sec., Chief Financial Officer of Avid Bioservices and Corp. Sec. of Avid Bioservices |
$
318.00K |
$
0 | Dr. Shelley P. M. Fussey Ph.D.,
VP of Intellectual Property |
$
275.00K |
$
0 | Mr. Joseph S. Shan M.P.H.,
VP of Clinical & Regulatory Affairs |
$
204.00K |
$
0 | Mr. Truc Le ,
Chief Operating Officer |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.31% Nasdaq 0.00%
Profile
